These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37572162)

  • 21. Evaluating 2-[
    Gjerum L; Frederiksen KS; Henriksen OM; Law I; Bruun M; Simonsen AH; Mecocci P; Baroni M; Dottorini ME; Koikkalainen J; Lötjönen J; Hasselbalch SG
    Neuroimage Clin; 2020; 27():102267. PubMed ID: 32417727
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Minoshima S; Cross D; Thientunyakit T; Foster NL; Drzezga A
    J Nucl Med; 2022 Jun; 63(Suppl 1):2S-12S. PubMed ID: 35649653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of FDG PET in Parkinson's disease and atypical parkinsonism associated with dementia.
    Walker Z; Gandolfo F; Orini S; Garibotto V; Agosta F; Arbizu J; Bouwman F; Drzezga A; Nestor P; Boccardi M; Altomare D; Festari C; Nobili F;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1534-1545. PubMed ID: 29779045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic pattern analysis of
    Gu SC; Ye Q; Yuan CX
    Rev Neurosci; 2019 Oct; 30(7):743-756. PubMed ID: 31050657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Typical cerebral metabolic patterns in neurodegenerative brain diseases.
    Teune LK; Bartels AL; de Jong BM; Willemsen AT; Eshuis SA; de Vries JJ; van Oostrom JC; Leenders KL
    Mov Disord; 2010 Oct; 25(14):2395-404. PubMed ID: 20669302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early perfusion and dopamine transporter imaging using
    Hong CM; Ryu HS; Ahn BC
    Am J Nucl Med Mol Imaging; 2018; 8(6):360-372. PubMed ID: 30697456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDG PET in the differential diagnosis of parkinsonian disorders.
    Eckert T; Barnes A; Dhawan V; Frucht S; Gordon MF; Feigin AS; Eidelberg D
    Neuroimage; 2005 Jul; 26(3):912-21. PubMed ID: 15955501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes.
    Garraux G; Phillips C; Schrouff J; Kreisler A; Lemaire C; Degueldre C; Delcour C; Hustinx R; Luxen A; Destée A; Salmon E
    Neuroimage Clin; 2013; 2():883-93. PubMed ID: 24179839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography.
    Tripathi M; Dhawan V; Peng S; Kushwaha S; Batla A; Jaimini A; D'Souza MM; Sharma R; Saw S; Mondal A
    Neuroradiology; 2013 Mar; 55(4):483-92. PubMed ID: 23314836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an optimized [
    Caminiti SP; Alongi P; Majno L; Volontè MA; Cerami C; Gianolli L; Comi G; Perani D
    Eur J Neurol; 2017 May; 24(5):687-e26. PubMed ID: 28244178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism.
    Akdemir ÜÖ; Tokçaer AB; Karakuş A; Kapucu LÖ
    Clin Nucl Med; 2014 Mar; 39(3):e220-6. PubMed ID: 24321825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.
    Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Kim JS
    Clin Nucl Med; 2017 Feb; 42(2):e80-e87. PubMed ID: 27922865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
    Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
    Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
    Wenning GK; Colosimo C
    Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
    J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A disease-specific metabolic brain network associated with corticobasal degeneration.
    Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
    Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
    Nicastro N; Burkhard PR; Garibotto V
    J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.